Presbia’s Flexivuea Micro-Lens Receives European Market Approval
Main Category: Eye Health / Blindness Also Included In: Regulatory Affairs / Drug Approvals Article Date: 10 Dec 2009 Presbia, a leader in the development and marketing of a surgical solution for presbyopia, today announced its Flexivue micro-lens received CE certification for its products sold within the European Economic Area .
source : www.topix.com
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Home Income Profit System
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Home Income Profit System
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Related News:
- Abbott Receives U.S. FDA Approval For New Cataract Multifocal Intraocular Lens
- Novo Nordisk Receives FDA Approval For Norditropin® FlexPro® For Growth Hormone Treatment
- OrthoDynamix LLC Receives FDA 510(k) Clearance For ArthroSteer(R) 3.5mm Ablator
- Sunridge Receives Approval For Its Non-Invasive Glaucoma Treatment In China
- Paloma Pharmaceuticals Receives Approval To Enter Phase I Clinical Trials
- Pervasis Therapeutics Receives FDA Clearance For Pivotal Phase 3 Trial Of Vascugel(R)
- Repros Receives Guidance From FDA Regarding Continued Development Of Androxal(R) In Hypogonadal Men
- Teva Receives Favorable Court Decision Regarding Generic Temodar(R)
- Glaucoma Research: IU Optometry’s Swanson Receives $2.35 Million From NIH
- Amgen Receives CHMP Positive Opinion For Prolia(TM) (Denosumab) In The European Union
Details :
Submited at Friday, December 11th, 2009 at 1:00 am on Surgical by admin
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















